|
Volumn 31, Issue 4, 2006, Pages 435-436
|
Letter to the Editor
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBON MONOXIDE;
CARBOXYHEMOGLOBIN;
NESIRITIDE;
PLACEBO;
BRAIN NATRIURETIC PEPTIDE;
ASYSTOLE;
CAUSE OF DEATH;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DRUG FATALITY;
DRUG SAFETY;
EMERGENCY HEALTH SERVICE;
FISHER EXACT TEST;
FOLLOW UP;
HEART FAILURE;
HUMAN;
LETTER;
LOG RANK TEST;
MORTALITY;
PRIORITY JOURNAL;
STANDARD;
STATISTICAL SIGNIFICANCE;
TRAFFIC ACCIDENT;
CONFIDENCE INTERVAL;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
CONFIDENCE INTERVALS;
FOLLOW-UP STUDIES;
HEART FAILURE, CONGESTIVE;
HUMANS;
MORTALITY;
NATRIURETIC PEPTIDE, BRAIN;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 33749525119
PISSN: 07364679
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jemermed.2006.10.001 Document Type: Letter |
Times cited : (6)
|
References (0)
|